Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

April 14, 2021

Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?

Indian Journal of Pathology & Microbiology
Viral BhanvadiaManju Sengar
April 14, 2021
Case Report
Open Access

TAFRO Syndrome With Kidney Involvement: A Case Series of Patients With Kidney Biopsies.

Kidney Medicine
Keiki ShimadaTakashi Yokoo
April 3, 2021
Open Access

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Alexandra ButzmannRobert S Ohgami
April 2, 2021
Open Access

Castelman's disease of the neck: a case report and literature review.

The Pan African Medical Journal
Amel El KorbiJamel Koubaa
March 31, 2021
Open Access

Autoimmune hypoglycemia expands the biological spectrum of HHV8+ multicentric Castleman disease.

Blood Advances
Pierre ArnautouDavid Boutboul
March 31, 2021
Open Access

Castleman disease and paraneoplastic pemphigus in a pregnant woman: A case report.

Beibei Cui, Hui Lin
March 22, 2021
Case Report
Open Access

Dermoscopic Features of Two Cases of Angiolymphoid Hyperplasia with Eosinophilia and Review of the Literature.

Dermatology Practical & Conceptual
Bengu Nisa AkayBanu Farabi
March 21, 2021
Open Access

18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.

Nuclear Medicine Communications
Yuanyuan JiangWuying Cheng
March 18, 2021
Open Access

Isolated middle mediastinal mass associated with immunoglobulin G4-related disease.

Surgical Case Reports
Haruaki HinoTomohiro Murakawa
March 16, 2021

Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease.

International Journal of Dermatology
Vishalakshi ViswanathPriyanka C Patil
March 13, 2021
Open Access

Emerging role of 18F-FDG PET/CT in Castleman disease: a review.

Insights Into Imaging
Benjamin KoaMona-Elisabeth Revheim
March 8, 2021
Open Access

Dichotomic response to interleukin-6 blockade in idiopathic multicentric Castleman disease: two case reports.

Journal of Medical Case Reports
Simone Ferrero, Simone Ragaini
March 9, 2021

[POEMS syndrome: Diagnosis, stratification, treatments].

La Revue de médecine interne
A TalbotB Arnulf
February 27, 2021
Open Access

Unicentric Castleman Disease; the laparoscopic en bloc resection of a hypervascular Giant Lymph Node in the aortacaval zone.

Journal of the Turkish German Gynecological Association
Baki ErdemGülseren Yılmaz
February 26, 2021
Open Access

Castleman disease: A single-center case series.

International Journal of Surgery Case Reports
Kyle PribylJames Harmon

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

4H Leukodystrophy

4H Leukodystrophy involves hypomyelination with hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3 Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. Here is the latest research on this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2021 Meta ULC. All rights reserved